SOUTH SAN FRANCISCO, Calif. & SOUTHAMPTON, U.K.--(BUSINESS WIRE)--VistaGen and Capsant have signed a strategic commercialization agreement under which the companies will combine their leading-edge stem cell biology and 3D cell culture platforms, respectively, to advance their mutual business interests worldwide.
